NPCE Company Profile and Key Details

Q: Who are the executives of NPCE?

Dr. Martha J. MorrellChief Medical OfficerMr. Joel D. BeckerChief Executive Officer & DirectorMs. Kelley NicholasVice President of SalesMr. Andre G. MarquetteChief Commercial OfficerMs. Chi NguyenVice President of MarketingMs. Rebecca L. KuhnChief Financial Officer, Vice President of Fin. & Admin. and Assistant Sec.Mr. Michael L. FavetPres, Chief Executive Officer & DirectorMs. Irene ThomasVice President of HRMs. Irina RidleyChief Legal Officer & Corporation Sec.

NASDAQ : NPCE

NeuroPace

$16.97

0.19+1.13%

At Close 4:00 PM

56.04

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

NeuroPace, Inc. (NPCE) stock surged +1.13%, trading at $16.97 on NASDAQ, up from the previous close of $16.78. The stock opened at $16.64, fluctuating between $16.63 and $17.21 in the recent session.

Stock Snapshot

16.78

Prev. Close

578.57M

Market Cap

16.63

Day Low

-29.26

P/E Ratio

-0.58

EPS (TTM)

-0.74

Cash Flow per Share

16.64

Open

34.09M

Number of Shares

17.21

Day High

68.06%

Free Float in %

0.77

Book Value

89.81K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jul 09, 2026	16.78	17.07	16.64	16.97	90.77K
Jul 08, 2026	17.53	17.99	16.66	16.78	109.12K
Jul 07, 2026	17.35	18.23	17.01	17.80	234.25K
Jul 06, 2026	16.29	17.46	16.24	17.33	181.36K
Jul 02, 2026	15.89	16.36	15.69	16.14	117.36K
Jul 01, 2026	15.89	16.29	15.56	15.77	188.17K
Jun 30, 2026	16.56	16.56	15.87	15.89	162.62K
Jun 29, 2026	16.47	16.66	16.10	16.53	160.94K
Jun 26, 2026	16.31	17.20	16.20	16.47	782.2K
Jun 25, 2026	16.37	16.74	16.17	16.36	145.95K
Jun 24, 2026	16.01	16.83	16.01	16.22	155.49K
Jun 23, 2026	15.32	16.09	15.32	15.92	250.89K
Jun 22, 2026	15.56	15.87	15.22	15.37	200.63K
Jun 18, 2026	15.52	15.65	15.14	15.63	168.46K
Jun 17, 2026	15.02	15.70	14.88	15.16	162.53K
Jun 16, 2026	15.50	15.67	14.88	15.02	110.82K
Jun 15, 2026	15.90	15.90	15.17	15.37	191.93K
Jun 12, 2026	15.85	15.98	15.62	15.64	83.78K
Jun 11, 2026	15.71	16.18	15.52	15.84	96.08K
Jun 10, 2026	15.95	16.43	15.65	15.71	87.48K

Contact Details

Mountain View, CA 94043

United States

https://www.neuropace.com 650 237 2700

About Company

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Stock Peers

ISRG

-3.55-0.86%

Intuitive Surgical, Inc.$411.55 SWAV

-0.08-0.02%

ShockWave Medical, Inc.$334.75 UFPT

-1.81-0.72%

UFP Technologies, Inc.$249.71 MASI

Masimo Corporation$179.95 ALGN

3.49+2.00%

Align Technology, Inc.$178.17 PODD

0.83+0.53%

Insulet Corp.$158.29 IRTC

-7.425-5.92%

iRhythm Technologies, Inc.$117.92 IRMD

1.73+1.80%

IRadimed Corporation$98.04 ESTA

0.78+0.89%

Establishment Labs Holdings Inc.$88.77 LIVN

0.01+0.01%

LivaNova PLC$82.52

Frequently Asked Questions

What is the current NeuroPace, Inc. (NPCE) stock price?

NeuroPace, Inc. (NASDAQ: NPCE) stock price is $16.97 in the last trading session. During the trading session, NPCE stock reached the peak price of $17.21 while $16.63 was the lowest point it dropped to. The percentage change in NPCE stock occurred in the recent session was 1.13% while the dollar amount for the price change in NPCE stock was $0.19.

NPCE's industry and sector of operation?

The NASDAQ listed NPCE is part of Medical - Devices industry that operates in the broader Healthcare sector. NeuroPace, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of NPCE?

Dr. Martha J. Morrell
Chief Medical Officer
Mr. Joel D. Becker
Chief Executive Officer & Director
Ms. Kelley Nicholas
Vice President of Sales
Mr. Andre G. Marquette
Chief Commercial Officer
Ms. Chi Nguyen
Vice President of Marketing
Ms. Rebecca L. Kuhn
Chief Financial Officer, Vice President of Fin. & Admin. and Assistant Sec.
Mr. Michael L. Favet
Pres, Chief Executive Officer & Director
Ms. Irene Thomas
Vice President of HR
Ms. Irina Ridley
Chief Legal Officer & Corporation Sec.

How NPCE did perform over past 52-week?

NPCE's closing price is 124.38% higher than its 52-week low of $7.56 where as its distance from 52-week high of $19.60 is -13.42%.

How many employees does NPCE have?

Number of NPCE employees currently stands at 203.

Link for NPCE official website?

Official Website of NPCE is: https://www.neuropace.com

How do I contact NPCE?

NPCE could be contacted at phone 650 237 2700 and can also be accessed through its website. NPCE operates from 455 North Bernardo Avenue, Mountain View, CA 94043, United States.

How many shares of NPCE are traded daily?

NPCE stock volume for the day was 89.81K shares. The average number of NPCE shares traded daily for last 3 months was 186.1K.

What is the market cap of NPCE currently?

The market value of NPCE currently stands at $578.57M with its latest stock price at $16.97 and 34.09M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	203
Beta	1.88
Sales or Revenue	$65.42M
5Y Sales Change%	0.631%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Devices

Employees	203
Beta	1.88
Sales or Revenue	$65.42M
5Y Sales Change%	0.631%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Devices

NPCE Company Profile and Key Details

NeuroPace

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Company Overview

Valuation Metrics

Price Forecast & Outlook

Key Takeaways